| 1 |
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al |
2:24-cv-09209 |
D.N.J. |
|
|
|
|
| 2 |
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al |
2:24-cv-09209 |
D.N.J. |
|
|
|
|
| 3 |
ViiV Healthcare Company et al v. Hetero USA Inc. et al |
1:24-cv-00907 |
D.Del. |
|
|
|
|
| 4 |
ViiV Healthcare Company et al v. Hetero USA Inc. et al |
1:24-cv-00907 |
D.Del. |
|
|
|
|
| 5 |
ViiV Healthcare Company et al v. Hetero USA Inc. et al |
1:24-cv-00907 |
D.Del. |
|
|
|
|
| 6 |
ESPERION THERAPEUTICS, INC. v. HETERO USA INC. et al |
2:24-cv-06389 |
D.N.J. |
|
|
|
|
| 7 |
ESPERION THERAPEUTICS, INC. v. MICRO LABS USA, INC. et al |
2:24-cv-05921 |
D.N.J. |
|
|
|
|
| 8 |
INTRA-CELLULAR THERAPIES, INC. v. HETERO USA, INC. et al |
3:24-cv-04317 |
D.N.J. |
|
|
|
|
| 9 |
MERCK SHARP & DOHME LLC v. HETERO USA, INC. et al |
2:22-cv-06820 |
D.N.J. |
|
|
|
|
| 10 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:20-cv-02601 |
D.N.J. |
|
|
|
|
| 11 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al |
1:20-cv-00277 |
D.Del. |
|
|
|
|
| 12 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al |
1:20-cv-00277 |
D.Del. |
|
|
|
|
| 13 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Annora Pharma Private Limited et al |
1:20-cv-00277 |
D.Del. |
|
|
|
|
| 14 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 15 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 16 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 17 |
Takeda Pharmaceuticals U.S.A., Inc. v. Hetero Labs Limited et al |
1:17-cv-01020 |
D.Del. |
|
|
|
|
| 18 |
Kowa Company, Ltd. et al v. Hetero Drugs Limited et al |
1:17-cv-00762 |
D.Del. |
|
|
|
|
| 19 |
Kowa Company, Ltd. et al v. Hetero Drugs Limited et al |
1:17-cv-00762 |
D.Del. |
|
|
|
|
| 20 |
Kowa Company, Ltd. et al v. Hetero Drugs Limited et al |
1:17-cv-00762 |
D.Del. |
|
|
|
|
| 21 |
CELGENE CORPORATION v. HETERO LABS LIMITED et al |
2:17-cv-03387 |
D.N.J. |
|
|
|
|
| 22 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. HETERO USA, INC. et al |
3:16-cv-02356 |
D.N.J. |
|
|
|
|
| 23 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. HETERO USA, INC. et al |
3:16-cv-02356 |
D.N.J. |
|
|
|
|
| 24 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. HETERO USA, INC. et al |
3:16-cv-02356 |
D.N.J. |
|
|
|
|
| 25 |
AbbVie Inc. et al v. Hetero USA Inc. et al |
1:15-cv-00889 |
D.Del. |
|
|
|
|
| 26 |
AbbVie Inc. et al v. Hetero USA Inc. et al |
1:15-cv-00889 |
D.Del. |
|
|
|
|
| 27 |
Otsuka Pharmaceutical Co. Ltd. v. Hetero USA Inc. et al |
1:14-cv-00421 |
D.Del. |
|
|
|
|
| 28 |
Forest Laboratories Inc. et al v. Hetero USA Inc. et al |
1:13-cv-01603 |
D.Del. |
|
|
|
|
| 29 |
Forest Laboratories Inc. et al v. Hetero USA Inc. et al |
1:13-cv-01603 |
D.Del. |
|
|
|
|
| 30 |
Forest Laboratories Inc. et al v. Hetero USA Inc. et al |
1:13-cv-01603 |
D.Del. |
|
|
|
|
| 31 |
UCB Inc. et al v. Hetero USA Inc. et al |
1:13-cv-01213 |
D.Del. |
|
- 8 Product company
- 1 Acquired patents
|
|
|
| 32 |
UCB Inc. et al v. Hetero USA Inc. et al |
1:13-cv-01213 |
D.Del. |
|
- 8 Product company
- 1 Acquired patents
|
|
|
| 33 |
UCB Inc. et al v. Hetero USA Inc. et al |
1:13-cv-01213 |
D.Del. |
|
- 8 Product company
- 1 Acquired patents
|
|
|
| 34 |
UCB Inc. et al v. Hetero USA Inc. et al |
1:13-cv-01213 |
D.Del. |
|
- 8 Product company
- 1 Acquired patents
|
|
|
| 35 |
Pfizer Inc. et al v. Alkem Laboratories Ltd. |
1:13-cv-01110 |
D.Del. |
|
|
|
|
| 36 |
Pfizer Inc. et al v. Alkem Laboratories Ltd. |
1:13-cv-01110 |
D.Del. |
|
|
|
|
| 37 |
AbbVie Inc. v. Hetero USA Inc. et al |
1:13-cv-00852 |
D.Del. |
|
|
|
|
| 38 |
AbbVie Inc. v. Hetero USA Inc. et al |
1:13-cv-00852 |
D.Del. |
|
|
|
|